Suppose that an investigator tested the treatment and no-tre…

Suppose that an investigator tested the treatment and no-treatment groups at very different times and in different places. In addition to the typical threats to the two-group design, the investigator would have to worry about ____, a threat to internal validity that usually doesn’t trouble researchers who use a two-group design.